These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 13212905)

  • 1. Clinical results of the treatment of prostatic carcinoma over a ten-year period.
    STAUBITZ WJ; OBERKIRCHER OJ; LENT MH
    J Urol; 1954 Nov; 72(5):939-45. PubMed ID: 13212905
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hormonal treatment of prostate tumors (adenoma and carcinoma)].
    BENLLOCH NAVARRO R
    Med Esp; 1954 Jul; 31(184):28-36. PubMed ID: 13223159
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of TACE as a therapeutic agent in prostatic carcinoma.
    O'CONOR VJ; SOKOL JK
    Q Bull Northwest Univ Med Sch; 1952; 26(2):161-2. PubMed ID: 14930215
    [No Abstract]   [Full Text] [Related]  

  • 4. [Thoughts on hormonal therapy of prostate carcinoma].
    BORNMANN G; LOESER A
    Dtsch Med Wochenschr; 1953 Jul; 78(27-28):970-1. PubMed ID: 13083156
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prostate carcinoma treated with male hormones].
    SCHULZE W
    Z Urol; 1954; Spec Issue():405-9. PubMed ID: 14360450
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormonal treatment in malignancy.
    JAMES AG
    Ohio State Med J; 1952 Sep; 48(9):817-20. PubMed ID: 12993429
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of hormonal therapy of prostatic cancer on serum aldolase.
    BAKER R; GOVAN D
    Cancer Res; 1953 Feb; 13(2):141-6. PubMed ID: 13042799
    [No Abstract]   [Full Text] [Related]  

  • 8. [An experiment in treatment of an estrogen resistant prostate carcinoma with male hormones].
    SCHULZE W
    Medizinische; 1955 Apr; 17():654-5. PubMed ID: 14383121
    [No Abstract]   [Full Text] [Related]  

  • 9. On the prevention and therapy of prostate cancer by androgen administration.
    Prehn RT
    Cancer Res; 1999 Sep; 59(17):4161-4. PubMed ID: 10485446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of prostate cancer by androgens: experimental paradox or clinical reality.
    Algarté-Génin M; Cussenot O; Costa P
    Eur Urol; 2004 Sep; 46(3):285-94; discussion 294-5. PubMed ID: 15306098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal responsiveness of prostatic carcinoma. In vitro technique for prediction.
    Mobbs BG; Johnson IE; Connolly JG
    Urology; 1974 Jan; 3(1):105-6. PubMed ID: 4130384
    [No Abstract]   [Full Text] [Related]  

  • 12. Androgen resistance in prostate cancer.
    Waxman J; Ngan S
    Br J Cancer; 2008 Jan; 98(1):1. PubMed ID: 18182971
    [No Abstract]   [Full Text] [Related]  

  • 13. [Improvement of medicaments in estrogen-resistant prostate carcinoma].
    BALVERS AG
    Ned Tijdschr Geneeskd; 1958 Sep; 102(38):1891-2. PubMed ID: 13600471
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hormone therapy of breast and prostate carcinoma].
    OBRECHT P
    Dtsch Med Wochenschr; 1957 Dec; 82(50):2117-21. PubMed ID: 13500952
    [No Abstract]   [Full Text] [Related]  

  • 15. [Present situation of treatment of cancer of the prostate].
    Röhl L; Hallwachs O
    Langenbecks Arch Chir; 1965 Aug; 311(3):263-71. PubMed ID: 5853898
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of prostatic cancer stage T3N0M0].
    Loran OB; Tomkevich BA
    Urologiia; 2004; (5):65-7. PubMed ID: 15560169
    [No Abstract]   [Full Text] [Related]  

  • 17. Words of Wisdom. Re: incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registries.
    Butler P; Scovell JM; Ramasamy R; Lipshultz LI
    Eur Urol; 2015 Jun; 67(6):1186-7. PubMed ID: 25944034
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of testosterone in men with prostate cancer and suggestions for an international registry.
    Morales A
    BJU Int; 2011 May; 107(9):1343-4. PubMed ID: 21518226
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.
    Huggins C; Hodges CV
    J Urol; 2002 Feb; 167(2 Pt 2):948-51; discussion 952. PubMed ID: 11905923
    [No Abstract]   [Full Text] [Related]  

  • 20. Intermittent hormonal therapy for prostate cancer.
    da Silva FC
    Curr Opin Urol; 2011 May; 21(3):248-51. PubMed ID: 21427583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.